The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.
CELESTICA INC. | ||||||||
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS | ||||||||
(in millions of U.S. dollars, except per share amounts) | ||||||||
(unaudited) | ||||||||
Three months ended | ||||||||
March 31 | ||||||||
Note | 2022 | 2023 | ||||||
Revenue | 3 | $ | 1,566.9 | $ | 1,837.8 | |||
Cost of sales | 5 | 1,434.4 | 1,673.8 | |||||
Gross profit | 132.5 | 164.0 | ||||||
Selling, general and administrative expenses | 65.7 | 77.9 | ||||||
Research and development | 11.4 | 12.1 | ||||||
Amortization of intangible assets | 10.0 | 10.0 | ||||||
Other charges | 8 | 4.8 | 4.6 | |||||
Earnings from operations | 40.6 | 59.4 | ||||||
Finance costs | 6 | 9.8 | 21.7 | |||||
Earnings before income taxes | 30.8 | 37.7 | ||||||
Income tax expense (recovery) | 9 | |||||||
Current | 13.5 | 17.9 | ||||||
Deferred | (4.5 | ) | (4.9 | ) | ||||
9.0 | 13.0 | |||||||
Net earnings for the period | $ | 21.8 | $ | 24.7 | ||||
Basic earnings per share | $ | 0.17 | $ | 0.20 | ||||
Diluted earnings per share | $ | 0.17 | $ | 0.20 | ||||
Shares used in computing per share amounts (in millions): | ||||||||
Basic | 124.6 | 121.5 | ||||||
Diluted | 124.7 | 121.6 |
The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.